Medicines Co. Asks Fed. Circ. To Reopen IP Fight With Mylan
The Medicines Co. on Tuesday asked the Federal Circuit to reopen a case in which it reversed an infringement ruling against Mylan Inc. for a patent for the anticoagulant Angiomax, as...To view the full article, register now.
Already a subscriber? Click here to view full article